MKI67 and neoplasm: Consistent with the phenotypic trend of the tumor tissues, the results of IHC showed that the expression of Ki67 was significantly higher in tumor tissues of the P+ group (33.19% ± 4.28%), about 1.5 times that of the control group (20.38% ± 2.54%) (p < 0.05).